Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036365 | SCV000060017 | uncertain significance | not specified | 2018-12-31 | criteria provided, single submitter | clinical testing | proposed classification - variant undergoing re-assessment, contact laboratory |
Gene |
RCV000766952 | SCV000209334 | uncertain significance | not provided | 2012-07-13 | criteria provided, single submitter | clinical testing | The Ala277Gly variant in the TPM1 gene has not been reported previously as a disease-causing mutation or as a benign polymorphism, to our knowledge. However, Ala277Val has been reported in a patient with severe idiopathic DCM who required a heart transplant at age 13, and Ala277Val was absent from 413 control individuals of various ethnic backgrounds (Hershberger R et al., 2010; Rampersaud E et al., 2011). However, this individual also harbored a mutation in the TNNT2 gene (Hershberger R et al., 2010; Rampersaud E et al., 2011). Ala277Gly is a conservative amino acid substitution of one non-polar amino acid for another at a position that is conserved across species. A mutation in a nearby codon (Met281Thr) has been reported in association with cardiomyopathy, supporting the functional importance of this region of the protein. Furthermore, the NHLBI ESP Exome Variant Server reports Ala277Gly was not observed in over 5,000 samples from individuals of European and African American backgrounds, indicating it is not a common variant in these populations. In summary, with the clinical and molecular information available at this time, we cannot determine whether Ala277Gly in the TPM1 gene is a disease-causing mutation or a benign variant. The variant is found in DCM panel(s). |